Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking

by Chuang G, Boyington JC, Nabel GJ, Kwong PD, Georgiev I
Published 2012-09-01

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

by Dai K, Boyington JC, Shi W, Schmidt SD, Georgiev I, Lingwood D, Kwong PD, Mascola JR, Yang Z, Nabel GJ
Published 2012-09-01

Partial germline reversions can increase VRC07 potency and breadth

by Rudicell RS, Georgiev I, Yang Z, O'Dell S, Kwon Y, Zhu J, Wu X, Kwong PD, Mascola JR, Nabel GJ
Published 2012-09-01

Structure-guided modification and optimization of antibody VRC07

by Kwon Y, Georgiev I, O'Dell S, Shi W, Chuang G, Yang Y, Zhang B, Zhu J, Nabel GJ, Mascola JR, Kwong PD
Published 2012-09-01

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization

by Acharya P, Luongo TS, Matz J, Schmidt SD, Chuang G, Georgiev I, Kessler P, Yang Y, Chames P, Martin L, Mascola JR, Kwong PD
Published 2012-09-01

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

by Joyce M, Zhang B, Zhou T, Moquin S, Wu X, Louder M, Zhang Z, Georgiev I, Zhu J, Shapiro L, Mascola JR, Nabel GJ, Kwong PD
Published 2012-09-01

Design of epitope-specific probes for sera analysis and antibody isolation

by Georgiev I, Acharya P, Schmidt SD, Li Y, Wycuff D, Ofek G, Doria-Rose N, Luongo TS, Yang Y, Zhou T, Donald BR, Mascola JR, Kwong PD
Published 2012-09-01

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

by Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR
Published 2012-09-01